期刊文献+

Researches on the Internal Molecular Weight Uniformity of Chitosan Biomaterials 被引量:1

Researches on the Internal Molecular Weight Uniformity of Chitosan Biomaterials
下载PDF
导出
摘要 Uniform molecular weight(Mw)chitosan(CS)is highly demanded in medical biomaterial industry.This present article described heterogeneous degradation of CS in aqueous HCl/ethanol solution,in which progress uniform Mw CS was successfully prepared.The Mw distribution of CS was measured by gel permeation chromatography(GPC)analysis.Moreover,the structure and properties of degraded CS were characterized by Fourier transform infrared spectroscopy(FT-IR),nuclear magnetic resonance spectroscopy(^1H NMR),X-ray diffraction(XRD)and thermogravimetric(TG)analysis.In addition,the biocompatibility of degraded CS was also assessed by hemolysis rate(HR)measurement.The Mw of CS dramatically decreased from 246 KDa to 76 k Da at the initial 30 min,and stabilized at 18 kDa after 24 h.GPC analysis results showed that the degraded CS molecular become homogenization.FT-IR and 1 H NMR analysis confirmed the basic structure of CS molecular backbone was not destroyed during this progress.Besides,the water solubility of CS was not significantly influenced by this reaction.Moreover,the XRD analysis revealed that crystallinity of degraded CS increased from 70.32% to 99.25%with time.The TG analysis showed improved thermal stability of degraded CS.HR measurement demonstrated the degraded CS possessed excellent biocompatibility.This simple and efficient heterogeneous degradation would open up a new route to produce uniform Mw CS. Uniform molecular weight(Mw) chitosan(CS) is highly demanded in medical biomaterial industry. This present article described heterogeneous degradation of CS in aqueous HCl/ethanol solution, in which progress uniform Mw CS was successfully prepared. The Mw distribution of CS was measured by gel permeation chromatography(GPC) analysis. Moreover, the structure and properties of degraded CS were characterized by Fourier transform infrared spectroscopy(FT-IR), nuclear magnetic resonance spectroscopy(1 H NMR), X-ray diffraction(XRD) and thermogravimetric(TG) analysis. In addition, the biocompatibility of degraded CS was also assessed by hemolysis rate(HR) measurement. The Mw of CS dramatically decreased from 246 KDa to 76 k Da at the initial 30 min, and stabilized at 18 kDa after 24 h. GPC analysis results showed that the degraded CS molecular become homogenization. FT-IR and 1 H NMR analysis confirmed the basic structure of CS molecular backbone was not destroyed during this progress. Besides, the water solubility of CS was not significantly influenced by this reaction. Moreover, the XRD analysis revealed that crystallinity of degraded CS increased from 70.32% to 99.25% with time. The TG analysis showed improved thermal stability of degraded CS. HR measurement demonstrated the degraded CS possessed excellent biocompatibility. This simple and efficient heterogeneous degradation would open up a new route to produce uniform Mw CS.
出处 《Journal of Ocean University of China》 SCIE CAS CSCD 2020年第2期459-465,共7页 中国海洋大学学报(英文版)
基金 supported by the National Natural Science Foundation of China(Nos.U1706212 and 81671828)
关键词 CHITOSAN heterogeneous degradation uniform molecular weight medical biomaterial chitosan heterogeneous degradation uniform molecular weight medical biomaterial
  • 相关文献

参考文献1

二级参考文献27

  • 1Chen C, Yu C H, Cheng Y C, et al. Biodegradable nanoparticles of amphiphilic triblock copolymers based on poly(3-hydroxybuty- rate) and poly(ethylene glycol) as drug carriers. Biomaterials, 2006, 27(27): 4804-4814.
  • 2Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urologic Oncology, 2008, 26(1): 57-64.
  • 3Malam Y, Loizidou M, Seifalian A M. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends in Pharmacological Sciences, 2009, 30(11): 592-599.
  • 4Byrne J D, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Advanced Drug Delivery Reviews, 2008, 60(15): 1615-1626.
  • 5Sudimack J, Lee R J. Targeted drug delivery via the folate receptor. Advanced Drug Delivery Reviews, 2000, 41(2): 147- 162.
  • 6Hruz P W, Mueckler M M. Structural analysis of the GLUT1 facilitative glucose transporter. Molecular Membrane Biology, 2001, 18(3): 183-193.
  • 7Olson A L, Pessin J E. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annual Review of Nutrition, 1996, 16(1): 235-256.
  • 8Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. The Journal of General Physiology, 1927, 8(6): 519-530.
  • 9Cullinane C, Solomon B, Hicks R J. Imaging of molecular target modulation in oncology: challenges of early clinical trials. Clinical and Translational Imaging, 2014, 2(1): 5-12.
  • 10Liu D Z, Sinchaikul S, Reddy P V G, et al. Synthesis of 2'- paclitaxel methyl 2-glucopyranosyl succinate for specific targeted delivery to cancer cells. Bioorganic & Medicinal Chemistry Letters, 2007, 17(3): 617-620.

共引文献2

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部